HIV Vaccines: Progress and Prospects
joint with HIV Pathogenesis
Organizer(s): Dan H. Barouch, John R. Mascola and M. Juliana McElrathDate: March 27 - April 01, 2008
Location: Fairmont Banff Springs, Banff, AB, Canada
The development of a safe and effective HIV-1 vaccine remains one of the highest research priorities. Several vaccine candidates are currently being evaluated in large-scale clinical trials, but numerous challenges remain. Immunogens that elicit broadly reactive neutralizing antibodies remain elusive. Vaccine vectors that induce cellular immune responses will likely require considerable improvement. Immune correlates of protection are not clearly defined, and the challenges of extensive worldwide viral sequence diversity remain. In this Keystone Symposia meeting, leading experts in the field will discuss recent advances in novel vaccine approaches, humoral and cellular immunity, immune correlates of protection, and early and late phase clinical trials. Vaccine-elicited immunity, translational vaccine development, and the Global HIV/AIDS Vaccine Enterprise will be highlighted.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Merck Research Laboratories
Roche Molecular Systems